Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Clinical and Cellular Immunology Année : 2015

Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

Résumé

Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now being used as oncolytic viruses in clinical trials to treat several types of cancer. The efficacy of oncolytic viruses is mainly due to their capacity to infect and kill tumor cells, but it has also been demonstrated that their capacity to induce immunogenic cell death can activate an antitumor immune response. In this review, we describe the oncolytic capacity of MV and the concept of Immunogenic Cell Death (ICD). We then review how MV induces immunogenic cell death, which can be beneficial for cancer treatment.
Fichier principal
Vignette du fichier
induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.pdf (306.63 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-01148993 , version 1 (06-05-2015)

Identifiants

Citer

Carole Achard, Nicolas Boisgerault, Tiphaine Delaunay, Frédéric Tangy, Marc Grégoire, et al.. Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus. Journal of Clinical and Cellular Immunology, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩. ⟨inserm-01148993⟩
213 Consultations
273 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More